From history taking and clinical suspicion to confirmation of sensitization and guidance of the therapeutic decision, each stage has its own medical logic and its own diagnostic tool.
Allergology seen through the patient pathway means choosing the right test, at the right time, for the right patient.
From history taking and clinical suspicion through to confirmation of sensitization and guidance of the therapeutic decision, each stage has its own medical logic and its own dedicated diagnostic tool.
ImmunoCAP™ supports this diagnostic pathway through a stepwise, coherent approach adapted to the clinical context.
In everyday practice, the family doctor or paediatrician can start the allergy assessment with a screening test, such as Phadiatop™ or Phadiatop™ Infant, when IgE-mediated allergy is suspected.
If the result is positive, the next step is to identify the relevant allergens by measuring specific IgE against whole allergens.
In complex cases, in polysensitization, in severe reactions, or when primary sensitization has to be distinguished from cross-reactivity, molecular testing with allergen components can be recommended.
This stepwise approach helps to build a clearer sensitization profile and provides a solid basis for clinical interpretation and for choosing the appropriate management.

* To be interpreted according to the symptoms, the clinical history and other results, such as skin tests or provocation tests.
** Clinical questions.
